4th LNP Characterization & Analytical Development

About this event

As LNP systems become more sophisticated and RNA therapeutics move toward targeted delivery, multi-cargo constructs, and increasingly complex modalities, the demands on characterization and analytical development have never been greater.

Traditional approaches are no longer sufficient to define product quality, understand structure-function relationships, or meet evolving regulatory expectations. The 4th LNP Characterization & Analytical Development Summit is the only dedicated forum focused exclusively on solving the analytical and characterization challenges shaping the future of LNP-enabled medicines.

Join analytical development, characterization, formulation, and CMC leaders from across pharma and biotech to uncover the latest advances in predictive CQAs, structural characterization, targeted LNP analytics, multi-attribute methods, and strategies for complex payload systems. Through technical case studies, interactive discussions, poster presentations, and high-value networking, gain practical insight into how the industry is accelerating development while reducing risk.

As innovation in RNA medicines continues to outpace analytical standards, this is the critical meeting point to benchmark approaches, shape future best practice, and stay ahead of the next generation of LNP development.

From Hanson Wade